Post #43937 by PucksFool on the US Policy board

Halls of Shrewd'm / US Policy ❤

Unthreaded | Threaded | Whole Thread (3)

Post New | Post Reply | Report Post | Recommend It!

No. of Recommendations: 2

... maybe p-Tau 217 screening should be part of a routine physical.

https://erictopol.substack.com/p/the-breakthrough-...
Since that discovery of a blood biomarker for Alzheimer’s disease, there has been remarkable further advances, including the availability of the test over the past year at a cost of approximately $200. In this edition of Ground Truths, I’ll go through the key questions as follows:

1 What is p-Tau217 measuring?
- How does it compare with other phosphorylated Tau proteins, CSF and PET scans?
2 How can we predict AD over 20 years in advance?
3 What can be done to lower p-Tau 217?
4 Where is this field headed?

Post New | Post Reply | Report Post | Recommend It!

Print the post

Unthreaded | Threaded | Whole Thread (3)

Prev | Next

Announcements

US Policy FAQ

Contact Shrewd'm
Contact the developer of these message boards.

A community forum supporting civilized, and highly helpful, self-educating investors that come together for Shrewdness and merry spirits. These message boards closely follow the look and feel of the old message boards at boards.fool.com prior to the boards redirected to discussion.fool.com. Shrewd'm is not affiliated with the comprehensive and excellent investment website, The Motley Fool (TMF), in any way. The Shrewd commmunity here has owed, and continues to owe, gratitude to The Motley Fool for nurturing a culture of jovial irreverence towards Wall St, and that tradition will continue here.